Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

BACKGROUND: Currently, there is no standard treatment for managing relapse in patients with acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after allogeneic hematopoietic cell transplantation. Venetoclax-based therapies have been increasingly used for treating post-transplantation rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yufeng, Li, Chunhong, Zhao, Zhijia, Liu, Yikun, Zhang, Chengtao, Yan, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433628/
https://www.ncbi.nlm.nih.gov/pubmed/37592239
http://dx.doi.org/10.1186/s12885-023-11259-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433628/
https://www.ncbi.nlm.nih.gov/pubmed/37592239
http://dx.doi.org/10.1186/s12885-023-11259-6

Ejemplares similares